Artificial Intelligence (AI) and MBC
AI (Artificial Intelligence) is being studied for its ability to improve clinical trials, predict response to treatment, and more. Read below to learn more about how AI may help people with MBC.
Meet the Clinical Trial Team: The Principal Investigator
We continue our series by highlighting the principal investigator, who is responsible for the overall management of the trial.
Living Beyond Breast Cancer Conference 2023
LBBC’s Thriving Together MBC conference was held from April 28-30, 2023. Click to view conference highlights and recordings.
Non-Treatment Trials: Managing Side Effects
This month, we are starting a series highlighting non-treatment (or non-interventional) trials, beginning with trials that study ways to prevent, reduce, or manage side effects.
Shared Decision-Making: Collaborating with Your Doctors About Your Cancer Care
Hear from experts about how to be more in control of your healthcare choices, based on risks, benefits, and your personal goals.
The Latest Research on Lobular MBC
Lobular MBC is harder to detect and spreads to different places in the body compared to ductal MBC. Click to learn more about recent research and clinical trials for lobular MBC.
Miami Breast Cancer Conference 2023
Read MBC research highlights from the 2023 Miami Breast Cancer Conference.
Managing Other Health Conditions While Living with MBC
Learn how to manage comorbidities while living with MBC and see a list of clinical trials that study comorbidities in people with MBC.
Can I Participate in a MBC Clinical Trial if I Have Other Health Conditions?
Read about how other health conditions you may have, called comorbidities, affect trial participation, as well as efforts to include more people with comorbidities in trials.
Meet the Clinical Trial Team: The Clinical Trial Coordinator
First in our new series, learn about how the clinical trial coordinator supports you before and during your clinical trial journey.